Trials / Completed
CompletedNCT00951119
Device-guided Breathing Exercises on Blood Pressure in Diabetic Patients
The Effect of Device-guided Breathing Exercises on Blood Pressure in Diabetic Patients With Hypertension (Resperate-3) A Randomized, Double-blind Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Medical Research Foundation, The Netherlands · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Rationale: Hypertension is an important risk factor of cardiovascular disease, especially in patients with type 2 diabetes mellitus (T2DM). A relatively recent development for the treatment of hypertension is the use of breathing exercises. The investigators' previous studies with a breathing device did not show any positive results. However, these studies and other trials investigating the effects of breathing devices had not a double-blind design. Therefore, the investigators want to perform a randomized, double-blind, controlled trial in a population of T2DM patients. Objective: To determine the effect of a device slowing breathing (Resperate©) on office systolic blood pressure (SBP) in diabetic patients with treated hypertension with moderate BP control. Study design: A randomized, double-blind, controlled trial. Study population: Patients with type 2 diabetes mellitus, over 18 years old and a baseline systolic blood pressure between 140-160 mm Hg. Intervention: One group receives treatment with a breathing device (Resperate©) and the other group receives treatment with a "control" breathing device. The latter device does not try to alter the breathing pattern. Main study parameters/endpoints: The effect of the breathing device on SBP is the main study parameter. Secondary endpoints include diastolic blood pressure (DBP) and quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Resperate | device-guided breathing exercises |
| DEVICE | Resperate | breathing device without slowing of breathing frequency |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2012-05-01
- Completion
- 2012-06-01
- First posted
- 2009-08-04
- Last updated
- 2012-10-24
Locations
2 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00951119. Inclusion in this directory is not an endorsement.